全文获取类型
收费全文 | 884篇 |
免费 | 50篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 74篇 |
妇产科学 | 5篇 |
基础医学 | 97篇 |
口腔科学 | 44篇 |
临床医学 | 73篇 |
内科学 | 184篇 |
皮肤病学 | 40篇 |
神经病学 | 27篇 |
特种医学 | 149篇 |
外国民族医学 | 1篇 |
外科学 | 71篇 |
综合类 | 39篇 |
预防医学 | 56篇 |
眼科学 | 5篇 |
药学 | 45篇 |
中国医学 | 1篇 |
肿瘤学 | 27篇 |
出版年
2021年 | 3篇 |
2020年 | 4篇 |
2019年 | 7篇 |
2018年 | 11篇 |
2017年 | 13篇 |
2016年 | 13篇 |
2015年 | 25篇 |
2014年 | 13篇 |
2013年 | 31篇 |
2012年 | 24篇 |
2011年 | 27篇 |
2010年 | 32篇 |
2009年 | 48篇 |
2008年 | 25篇 |
2007年 | 19篇 |
2006年 | 20篇 |
2005年 | 18篇 |
2004年 | 32篇 |
2003年 | 20篇 |
2002年 | 13篇 |
2001年 | 10篇 |
2000年 | 6篇 |
1999年 | 22篇 |
1998年 | 56篇 |
1997年 | 62篇 |
1996年 | 56篇 |
1995年 | 42篇 |
1994年 | 41篇 |
1993年 | 37篇 |
1992年 | 7篇 |
1991年 | 12篇 |
1990年 | 17篇 |
1989年 | 16篇 |
1988年 | 24篇 |
1987年 | 24篇 |
1986年 | 21篇 |
1985年 | 10篇 |
1984年 | 4篇 |
1983年 | 8篇 |
1982年 | 18篇 |
1981年 | 3篇 |
1980年 | 9篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1976年 | 6篇 |
1975年 | 2篇 |
1968年 | 3篇 |
1967年 | 2篇 |
1959年 | 2篇 |
排序方式: 共有943条查询结果,搜索用时 78 毫秒
31.
32.
33.
A Bahrami Y Rassi N Maleki MA Oshaghi M Mohebali MR Yagoobi-Ershadi S Rafizadeh 《亚太热带病杂志(英文版)》2014,4(2):110-114
Objective
To identify the vector(s), the parasite and the species composition of sand flies in the district during May-October 2012.Methods
For reaching our objectives we used polymerase chain reaction of kDNA, ITS1-rDNA, followed by restriction fragment length polymorphism.Results
Two species of Phlebotomus sergenti and Phlebotomus tobbi were the most prevalent among 8 species identified comprising 51.1% and 32.9% respectively. Among the 160 specimens of female sand flies tested by polymerase chain reaction of kDNA, ITS1-rDNA, followed by restriction fragment length polymorphisms, only 1 out of 80 Phlebotomus tobbi (1.25%) were positive to Leishmania infantum parasites.Conclusions
Our finding showed that Phlebotomus tobbi may play as a vector to circulate the parasite of Leishmania infantum among reservoir(s) and human. 相似文献34.
Jonas MM Balistreri W Gonzalez-Peralta RP Haber B Lobritto S Mohan P Molleston JP Murray KF Narkewicz MR Rosenthal P Schwarz KB Barton BA Shepherd JA Mitchell PD Duggan C 《Hepatology (Baltimore, Md.)》2012,56(2):523-531
Weight loss and changes in growth are noted in children treated with interferon alpha (IFN-α). The aim of this study was to prospectively determine changes in weight, height, body mass index (BMI), and body composition during and after treatment of children with hepatitis C virus (HCV). Children treated with pegylated interferon alpha-2a (Peg-IFN-α2a) ± ribavirin in the Pediatric Study of Hepatitis C (PEDS-C) trial underwent anthropometric measurements, dual-energy X-ray absorptiometry scan, as well as dietary and activity assessments during and after treatment. One hundred and fourteen (55% male) children, with a mean age of 11 ± 3 years, were randomized, and 107 received treatment for at least 24 weeks. Subjects were divided into three groups according to duration of treatment: 24 (N = 14), 48 (N = 82), or 72 (N = 11) weeks. Decrements of up to 0.50 z score were observed for weight, height, and BMI while on therapy among all groups (P ≤ 0.01, compared to baseline). In the group treated for 48 weeks, 29 (33%) subjects had greater than 0.5-unit decrement in height-for-age z (HAZ) score. Though weight-for-age and BMI z scores returned to baseline after cessation of therapy, mean HAZ score was slower to rebound, still lower than baseline at 96 weeks post-therapy for the long-treatment duration group (P = 0.03) and lower than baseline in most children treated for 48 weeks. Percent body fat, fat-free mass z scores, and triceps skinfold z scores decreased with therapy. Dietary energy intake and levels of physical activity did not change during treatment. CONCLUSIONS: Peg-IFN-α2a was associated with significant changes in body weight, linear growth, BMI, and body composition in children. These effects were generally reversible with cessation of therapy, although HAZ scores had not returned to baseline after 2 years of observation in many. Longer term growth data are needed among children treated for chronic HCV. 相似文献
35.
36.
37.
S Dixon AW Blom MR Whitehouse V Wylde 《Annals of the Royal College of Surgeons of England》2014,96(1):61-66
INTRODUCTION
The Triathlon® (Stryker, Kalamazoo, MI, US) total knee replacement was designed to improve patient function and survivorship. The aim of this study was to determine whether the Triathlon® prosthesis produces better patient reported outcomes than a previous design by the same manufacturer, the Kinemax Plus.METHODS
The outcome of 233 knees of patients with a mean age of 68 years (range: 40–80 years) who received the Kinemax Plus prosthesis were compared with the outcomes of 220 knees of patients with a mean age of 70 years (range: 42–90 years) who received the Triathlon® prosthesis. Data were collected via postal questionnaire prior to surgery as well as at 8–12 weeks and at 1 year following surgery. Validated questionnaires were used including the WOMAC® (Western Ontario and McMaster Universities) pain and function scales, the Knee injury and Osteoarthritis Outcome Score quality of life scale and the self-administered patient satisfaction scale.RESULTS
This study found that patients who had the Triathlon® prosthesis had significantly better pain relief (p<0.0001), function (p=0.028), knee related quality of life (p<0.0001) and satisfaction (p=0.0003) at three months after surgery than those who received the Kinemax Plus prosthesis. In addition, knee related quality of life (p=0.002) and satisfaction (p=0.021) were significantly higher at one year after surgery in Triathlon® patients.CONCLUSIONS
The findings suggest that return to function and reduction in pain may occur more quickly in patients with a Triathlon® prosthesis than in those with the Kinemax Plus. 相似文献38.
39.
Inaccuracies associated with the automated measurement of mean cell hemoglobin concentration in dehydrated cells 总被引:1,自引:0,他引:1
Because of discrepancies between electronically and manually measured values of mean cell hemoglobin concentration (MCHC) encountered in studies of pathologic red cells, we studied the effect of cell water content on MCHC measurements by both methods. A series of red cell samples with varying water contents (54%-164% normal) were prepared from normal cells using the antibiotic nystatin. MCHC was then measured, using the microhematocrit centrifuge and three different electronic cell counters in common laboratory use. For MCHC values above 36 g/dl as measured by the spun hematocrit method, all three electronic counters under estimmated the MCHC, with increasing error as the true MCHC increased. For MCHC values below 30 g/dl, the values from two conductivity based instruments agreed with those from the spun hematocrit method, whereas one instrument based on light scattering overestimated the MCHC. These results indicate that inaccuracies in the measured mean cell volume (MCV) of dehydrated or otherwise undeformable cells may lead to spurious values for MCHC when electronic cell counters are used. 相似文献
40.
Michael R. Narkewicz Simon Horslen Regina M. Hardison Benjamin L. Shneider Norberto Rodriguez-Baez Estella M. Alonso Vicky L. Ng Mike A. Leonis Kathleen M. Loomes David A. Rudnick Philip Rosenthal Rene Romero Girish C. Subbarao Ruosha Li Steven H. Belle Robert H. Squires 《Clinical gastroenterology and hepatology》2018,16(11):1801-1810.e3